Finnish Healthcare Profitable Climbers

Revenio Group Oyj

Market Cap: €329.9m

Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.

Nexstim

Market Cap: €79.9m

A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.